Skip to Content

'
Jennifer K. Burzawa, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement


Dr. Jennifer K. Burzawa, is an Assistant Professor in the Department of Gynecologic Oncology & Reproductive Medicine since 2012 and is affiliated with the expanding Gynecologic Oncology services at the Regional Care Center of Katy.  Dr. Burzawa previously was a Clinical Specialist in the Department of Gynecologic Oncology from 2010 to 2012. She is board eligible by the American Board of Obstetrics and Gynecology & Gynecologic Oncology.

Dr. Burzawa received her M.D. degree from The University of Miami School of Medicine at Miami in 2004.  After completing a residency in Obstetrics and Gynecology in 2008 at Baylor College of Medicine at Houston, Dr. Burzawa came to M.D. Anderson as a Fellow in the Department of Gynecologic Oncology.  Since arriving at M.D. Anderson in 2008, Dr. Burzawa has completed a fellowship and participated on several institutional committees, such as the Fellowship Planning Committee, Fellowship Didactic Curriculum Subcommittee and the Fellowship Admissions Subcommittee in the department of Gynecologic Oncology. 
She is also a member of the active, provisional, or consulting staff of five local hospitals. 

In addition to her clinical and educational duties, Dr. Burzawa has served on several institutional committees within the department, such as the Fellowship Planning Committee, Fellowship Didactic Curriculum Subcommittee and the Fellowship Admissions Subcommittee.  Currently,  Dr. Burzawa has written numerous articles published in refereed journals and abstracts on an array of topics pertaining to gynecologic cancer.  Dr. Burzawa continues to pursue her clinical and educational goals at M.D. Anderson Cancer Center, Regional Care.

Office Address

The University of Texas MD Anderson Cancer Center
Department of Gynecologic Oncology and Reproductive Medicine
1155 Pressler Street
Unit Number: 1362
Houston, TX 77030
Phone: 713-794-1387
Fax: 713-792-7586
The University of Texas MD Anderson Cancer Center
Regional Care Center Katy
19770 Kingsland Blvd, Ste. 200
Unit Number: 2052
Houston, TX 77094
Phone: 713-563-9600
Fax: 281-646-4320

Education & Training

Degree-Granting Education

2000 University of Miami, Coral Gables, FL, BS, Medicine

Postgraduate Training

2008-2012 Clinical Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2006 Fellowship, Felix Rutledge Fellowship - Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2004-2008 Clinical Residency, Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX

Board Certifications

4/2015 American Board of Obstetrics and Gynecology - Gynecologic Oncology
11/2013 American Board of Obstetrics and Gynecology- Obstetrics & Gynecology

Selected Publications

Peer-Reviewed Original Research Articles

1. Pakish JB, Lu KH, Sun CC, Burzawa JK, Greisinger A, Smith FA, Fellman B, Urbauer DL, Soliman PT. Endometrial Cancer Associated Symptoms: A Case-Control Study. J Womens Health (Larchmt). e-Pub 6/2/2016. PMID: 27254529.
2. Frumovitz M, Burzawa JK, Byers LA, Lyons YA, Ramalingam P, Coleman RC, Brown J. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer. Gynecol Oncol 141(3):588-91, 6/2016. e-Pub 4/15/2016. PMCID: PMC4877250.
3. Arms RG, Sun CC, Burzawa JK, Fleming ND, Nick AM, Rallapalli V, Westin SN, Meyer LA, Ramirez PT, Soliman PT. Improvement in quality of life after robotic surgery results in patient satisfaction. Gynecol Oncol 138(3):727-30, 9/2015. e-Pub 7/18/2015. PMCID: PMC4816594.
4. dos Reis R, Burzawa JK, Tsunoda AT, Hosaka M, Frumovitz M, Westin SN, Munsell MF, Ramirez PT. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer. Int J Gynecol Cancer 25(7):1292-9, 9/2015. e-Pub 6/9/2015. PMCID: PMC4549160.
5. Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther 15(7):805-10, 7/2015. e-Pub 5/17/2015. PMID: 25980782.
6. Zaid T, Burzawa J, Basen-Engquist K, Bodurka DC, Ramondetta LM, Brown J, Frumovitz M. Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol 132(1):149-53, 1/2014. e-Pub 10/19/2013. PMCID: PMC4265467.
7. Iglesias DA, Yates MS, van der Hoeven D, Rodkey TL, Zhang Q, Co NN, Burzawa J, Chigurupati S, Celestino J, Bowser J, Broaddus R, Hancock JF, Schmandt R, Lu KH. Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy. Mol Cancer Ther 12(12):2847-56, 12/2013. e-Pub 9/27/2013. PMCID: PMC3883498.
8. Huang M, Djordjevic B, Yates MS, Urbauer D, Sun C, Burzawa J, Daniels M, Westin SN, Broaddus R, Lu K. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome. Cancer 119(16):3027-33, 8/15/2013. e-Pub 6/12/2013. PMCID: PMC4120439.
9. Zhang Q, Celestino J, Schmandt R, McCampbell AS, Urbauer DL, Meyer LA, Burzawa JK, Huang M, Yates MS, Iglesias D, Broaddus RR, Lu KH. Chemopreventive effects of metformin on obesity-associated endometrial proliferation. Am J Obstet Gynecol 209(1):24.e1-24.e12, 7/2013. e-Pub 3/15/2013. PMCID: PMC3819145.
10. Daniels MS, Burzawa JK, Brandt AC, Schmeler KM, Lu KH. A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges. Fam Cancer 10(2):193-7, 6/2011. PMCID: PMC4286250.
11. Burzawa JK, Schmeler KM, Soliman PT, Meyer LA, Bevers MW, Pustilnik TL, Anderson ML, Ramondetta LM, Tortolero-Luna G, Urbauer DL, Chang S, Gershenson DM, Brown J, Lu KH. Prospective evaluation of insulin resistance among endometrial cancer patients. Am J Obstet Gynecol 204(4):355.e1-7, 4/2011. e-Pub 2/16/2011. PMCID: PMC4286377.
12. Huang M, Sun C, Boyd-Rogers S, Burzawa J, Milbourne A, Keeler E, Yzquierdo R, Lynch P, Peterson SK, Lu K. Prospective study of combined colon and endometrial cancer screening in women with lynch syndrome: a patient-centered approach. J Oncol Pract 7(1):43-7, 1/2011. PMCID: PMC3014510.
13. Nick AM, Schmeler KM, Frumovitz MM, Soliman PT, Spannuth WA, Burzawa JK, Coleman RL, Wei C, dos Reis R, Ramirez PT. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 116(4):956-61, 10/2010. PMID: 20859161.
14. Li Z, Burzawa JK, Troung A, Feng S, Agoulnik IU, Tong X, Anderson ML, Kovanci E, Rajkovic A, Agoulnik AI. Relaxin signaling in uterine fibroids. Ann N Y Acad Sci 1160:374-8, 4/2009. PMCID: PMC2954601.
15. Latchaw G, Takacs P, Gaitan L, Geren S, Burzawa J. Risk factors associated with the rupture of tubal ectopic pregnancy. Gynecol Obstet Invest 60(3):177-80, 2005. e-Pub 9/2/2005. PMID: 16141721.
16. Kraus G, Geffin R, Spruill G, Young AK, Seivright R, Cardona D, Burzawa J, Hnatyszyn HJ. Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Proc Natl Acad Sci U S A 99(6):3406-11, 3/19/2002. PMCID: PMC122536.

Abstracts

1. Huang M, Sun CC, Boyd-Rogers, Burzawa JK, Milbourne A, etal. A prospective study of combined colon and endometrial cancer screening in women with Lynch Syndrome: A Novel, Patent Center Approach. J. Clinical Oncology 28(15s) (#1563), 2010.
2. Huang M, Djordjevic B, Urbauer D, CC Sun, Westin SN, etal. Molecular Analysis of Endometrial Pathogenesis in Lynch Syndrome. J. Clinical Oncology, 2010.
3. Burzawa JK, Schmandt R, Bowser J, Zhang Q, etal. Preclinical evidence for exercise and pharmacologic exercise mimetics in the treatment of endometrial cancer. Gynecology Oncology 116(s80), 2010.
4. Huang M, Burzawa J, Djordjevic B, etal. Preinvasive disease in patients with Lynch syndrome-associated endometrial cancer. Gynecology Oncology, 2010.
5. Nick A, Schmeler K, Frumovitz M, Soliman P, Spannuth W, Burzawa J, etal. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Gynecology Oncology s146 (#383), 2010.
6. Myers LA, Anderson ME, Lacour RA, Westin SN, Burzawa JK, etal. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: A trend over time. Gynecology Oncology 112(s96), 2009.
7. Burzawa JK, Schmeler KM, Soliman PT, etal. Prospective, population-based evaluation of insulin resistance, polycystic ovary syndrome and metabolic syndrome in a cohort of patients with endometrial cancer. Gynecologic Oncology 112(s85), 2009.

Last updated: 6/14/2016